Percutaneous Dilational Tracheotomy in Solid-Organ Transplant Recipients

Area of Science:

• Medical research
• Transplant surgery
• Pulmonology

Background:

• Solid-organ transplant recipients often require prolonged mechanical ventilation.
• Percutaneous dilational tracheotomy (PDT) is a potential airway management solution.
• Limited data exist on PDT safety and efficacy in this specific patient population.

Purpose of the Study:

• To evaluate the safety and effectiveness of PDT in solid-organ transplant recipients.
• To assess improvements in lung mechanics, complications, and patient comfort post-PDT.
• To provide evidence for PDT as a viable airway management strategy in this cohort.

Main Methods:

• Retrospective analysis of 31 solid-organ transplant recipients undergoing PDT.
• Data collected included ventilation duration, ICU/hospital stays, and PDT-related complications.
• Assessment of pulmonary compliance and oxygenation (PaO2/FiO2 ratio) before and after PDT.

Main Results:

• PDT was associated with a significant improvement in pulmonary compliance (P = .001).
• Sedation requirements decreased significantly post-procedure (P = .004).
• A single case of pneumothorax was the only major complication; PaO2/FiO2 ratio showed no significant change (P = .052).

Conclusions:

• Bronchoscopically guided PDT is safe and effective for airway management in solid-organ transplant recipients requiring prolonged mechanical ventilation.
• The procedure offers potential benefits in ventilatory mechanics and patient comfort.
• PDT can be considered a valuable intervention for this patient group.